BioCentury
ARTICLE | Translation in Brief

Targeting pathogenic Th17 cells

How two new autoimmune targets drive pathogenic Th17 activity

March 1, 2019 1:48 AM UTC

A recent pair of studies offers two new approaches to treating autoimmune diseases that go after the source of Th17-mediated inflammation.

T helper type 17 (Th17) cells are effector T cells that secrete the cytokine IL-17. Normal Th17 activity is required for host defense against pathogens, but hyperactivity leads to autoimmune disorders such as multiple sclerosis, psoriasis and rheumatoid arthritis. ...